دورية أكاديمية
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
| العنوان: | Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022 |
|---|---|
| المؤلفون: | Sentís, Alexis, Kislaya, Irina, Nicolay, Nathalie, Meijerink, Hinta, Starrfelt, Jostein, Martínez-Baz, Iván, Castilla Catalán, Jesús, Nielsen, Katrine Finderup, Hansen, Christian Holm, Emborg, Hanne-Dorthe, Nardone, Anthony, Derrough, Tarik, Valenciano, Marta, Nunes, Baltazar, Monge, Susana, VEBIS-Lot4 working group, Larrauri, Amparo, Mazagatos, Clara |
| المساهمون: | Unión Europea. European Centre for Disease Prevention and Control (ECDC) |
| بيانات النشر: | Centers for Disease Control and Prevention (CDC) |
| سنة النشر: | 2022 |
| المجموعة: | REPISALUD (REPositorio Institucional en SALUD del Instituto de Salud Carlos III - ISCIII) |
| مصطلحات موضوعية: | COVID-19, Delta variant, Omicron variant, Vaccination booster dose, Vaccination primary course, Vaccine effectiveness, COVID-19 Vaccines, Aged, Electronics, Hospitalization, Humans, Pilot Projects, Registries, Vaccine Efficacy |
| الوصف: | By employing a common protocol and data from electronic health registries in Denmark, Navarre (Spain), Norway and Portugal, we estimated vaccine effectiveness (VE) against hospitalisation due to COVID-19 in individuals aged ≥ 65 years old, without previous documented infection, between October 2021 and March 2022. VE was higher in 65-79-year-olds compared with ≥ 80-year-olds and in those who received a booster compared with those who were primary vaccinated. VE remained high (ca 80%) between ≥ 12 and < 24 weeks after the first booster administration, and after Omicron became dominant. ; All the organisations involved have received funding from the European Centre for Disease Prevention and Control (ECDC) implementing Framework Contract ECDC/2021/018 ‘Vaccine effectiveness and impact of COVID-19 vaccines through routinely collected exposure and outcome using health registries’ (RS/2022/DTS/24104). ; Sí |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1560-7917 |
| العلاقة: | Euro Surveill. 2022 Jul;27(30):2200551.; http://hdl.handle.net/20.500.12105/15461Test; Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin |
| DOI: | 10.2807/1560-7917.ES.2022.27.30.2200551 |
| الإتاحة: | https://doi.org/20.500.12105/15461Test https://doi.org/10.2807/1560-7917.ES.2022.27.30.2200551Test https://hdl.handle.net/20.500.12105/15461Test |
| حقوق: | http://creativecommons.org/licenses/by/4.0Test/ ; Atribución 4.0 Internacional ; open access |
| رقم الانضمام: | edsbas.14AD0017 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 15607917 |
|---|---|
| DOI: | 10.2807/1560-7917.ES.2022.27.30.2200551 |